PATH three-lens brief
Evidence-based stock research on PATH. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Price down 5.99% in the last session — a material single-day move. · Trading at 1% of its 52-week range — deep in the lower band.
- Price down 5.99% in the last session — a material single-day move.
- Trading at 1% of its 52-week range — deep in the lower band.
- Underperforming SPY by 28.5pp over 30 days.
- Analyst mean target $13.62 — 45% above current (16 analysts).
- Debt-to-equity of 3.9 — balance-sheet-heavy.
PATH closed at $9.41 (-5.99%) as of 2026-05-13. Market cap: $4.93B. P/E (trailing) 18.1. Positives: analyst mean target $13.62 — 45% above current (16 analysts).. Concerns: price down 5.99% in the last session — a material single-day move.; trading at 1% of its 52-week range — deep in the lower band.. Last quarter: Revenue $481.11M, net income $104.46M, free cash flow $473.55M.
Why three lenses on PATH, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PATHacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PATH" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PATH brief"></iframe>